🌟 Vice President & Head of Cardiovascular Medicine
Are you ready to lead cardiovascular clinical strategy and development through one of the most exciting phases in a biotech company’s journey from pivotal global trials and regulatory submissions?
I'm partnered with established Biopharma that is hiring a VP & Head of Cardiovascular Medicine to shape, lead, and execute cutting‑edge cardiology clinical programs. This is a rare opportunity to make a defining impact on patient lives while driving innovation in a fast‑growing, mission‑driven organization.
What You’ll Do
- Lead and inspire cardiovascular clinical programs, serving as the internal and external subject matter expert (SME) for heart failure and cardiomyopathy.
- Serve as lead study physician / medical director for at least one pivotal clinical trial, overseeing design, execution, and regulatory submission activities.
- Develop and advise on clinical protocols, biomarkers, and imaging strategies to evaluate cardiac dysfunction and therapeutic interventions.
- Partner with cross‑functional teams, academic investigators, KOLs, steering committees, and Data Safety Monitoring Boards.
- Ensure compliance with GCP, ICH guidelines, FDA, and EMA regulations.
- Represent the organization externally at scientific conferences, advisory boards, and investigator meetings, providing thought leadership in cardiovascular medicine.
What You Bring
- MD or DO with board certification or substantial clinical experience in cardiology, preferably in heart failure or cardiomyopathy.
- 10+ years of progressive leadership experience in cardiovascular clinical programs, ideally in biopharma or clinical development.
- Demonstrated success leading global cardiovascular trials with experience in regulatory submissions (BLA/NDA/IND) strongly preferred.
- Deep understanding of cardiomyopathy and heart failure science, translational research, and clinical trial design.
- Proven ability to lead cross‑functional teams, influence strategy, and partner with internal and external stakeholders.